“Viome is rapidly scaling to become a global leader in the longevity space, to promote better health outcomes today and our future generations, with exceptional innovation. The Viome team continues to accelerate leading AI-driven techniques to analyze gut microbiome data, which is leading to breakthrough new discoveries to help solve the root causes of so many chronic diseases to benefit all of mankind.”
Harish Consul, Founder & CEO, Ocgrow Ventures
“The future of healthcare is individual and personalized, and few companies have been driving innovation in this space as rapidly as Viome. Through the company’s continued research, development, and advancements within chronic disorders, cancers, and aging, Viome is bringing us one step closer to a world without chronic illness.”
Vinod Khosla, Founder & CEO of Khosla Ventures
"I am impressed by Viome’s unparalleled ability to produce high-quality insights from both the microbiome and human cells. This allows Viome to understand the underlying reasons for a range of chronic diseases and make food & supplement recommendations whose goal is to prevent and reverse these diseases."
Alessio Fasano, Professor and Director of the Mucosal Immunology and Biology Research Center at Massachusetts General Hospital
"Viome is breaking new ground in developing precision recommendations of foods and supplements, and studying how these interventions can improve a range of chronic conditions, especially related to digestive and mood disorders. They are not only discovering the mechanisms underlying chronic diseases, but also developing new methods for improving the clinical outcomes using precision supplements interventions"
Emeran Mayer, Physician-scientist, UCLA Professor of Medicine, Physiology and Psychiatry